Salmonella Testing Market (2026 - 2035)

ID: MRFR/HC/37022-HCR 100 Pages Nidhi Mandole Last Updated: October 22, 2026
Salmonella Testing Market Research Report By Methodology (Polymerase Chain Reaction, Enzyme-Linked Immunosorbent Assay, Culture Method, Rapid Testing Kits), By Sample Type (Food Samples, Water Samples, Environmental Samples, Clinical Samples), By End Use (Food Industry, Pharmaceutical Industry, Environmental Testing, Clinical Diagnostics), By Technology (Molecular Diagnostics, Traditional Microbiological Methods, Immunological Testing, Nucleic Acid Testing) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2026 To 2035
Salmonella Testing Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)7.95%
2025 Market SizeUSD 3.68 Billion
2035 Market SizeUSD 7.91 Billion
Key Players
bioMérieux SA
Thermo Fisher Scientific
Neogen Corporation
Merck KGaA
Eurofins Scientific
Bio-Rad Laboratories
Opportunities
  • Point-of-Need Detection at the Production Line
  • Emerging-Market Laboratory Network Expansion
  • Data Monetisation Through Sequencing-as-a-Service
  1. 1 Market Summary | |
    1. 1.1 Study Assumptions & Market Definition | |
    2. 1.2 Scope of the Study | |
    3. 1.3 Research Methodology | |
  2. 2 Key Report Takeaways | |
    1. 2.1 By Offering | |
    2. 2.2 By Test Type | |
    3. 2.3 By Sample Type | |
    4. 2.4 By End-User | |
    5. 2.5 By Region | |
  3. 3 Market Size and Forecast (2021–2035) | |
    1. 3.1 Historical Market Size (2021–2025) | |
    2. 3.2 Current & Forecast Market Size (2026–2035) | |
    3. 3.3 Year-over-Year Growth Analysis | |
  4. 4 Driver Impact Analysis | |
    1. 4.1 FSMA 204 Traceability Enforcement | |
    2. 4.2 Feed and Pet Food Sampling Mandates | |
    3. 4.3 Migration to Rapid Molecular Platforms | |
    4. 4.4 Asia-Pacific Genomic Surveillance Networks | |
    5. 4.5 Outsourcing to Contract Laboratories | |
    6. 4.6 Alternative Protein Manufacturing Growth | |
    7. 4.7 Retailer Certification Schemes | |
  5. 5 Restraints Impact Analysis | |
    1. 5.1 High Per-Test Cost for Small Processors | |
    2. 5.2 Shortage of Trained Microbiologists | |
    3. 5.3 False Positives in Complex Matrices | |
    4. 5.4 Method Validation and Approval Lag | |
    5. 5.5 Fragmented Laboratory Data Standards | |
  6. 6 Opportunities | |
    1. 6.1 Point-of-Need Detection at the Production Line | |
    2. 6.2 Emerging-Market Laboratory Network Expansion | |
    3. 6.3 Data Monetisation Through Sequencing-as-a-Service | |
    4. 6.4 Water, Environmental and One Health Scope Expansion | |
    5. 6.5 Validated Chemistry for Alternative Protein Matrices | |
  7. 7 Regional Market Share and Country-Level Analysis | |
    1. 7.1 North America | | |
      1. 7.1.1 US | | |
      2. 7.1.2 Canada | | |
      3. 7.1.3 Mexico | |
    2. 7.2 Europe | | |
      1. 7.2.1 Germany | | |
      2. 7.2.2 UK | | |
      3. 7.2.3 France | | |
      4. 7.2.4 Italy | | |
      5. 7.2.5 Spain | | |
      6. 7.2.6 Nordic Countries | | |
      7. 7.2.7 Russia | | |
      8. 7.2.8 Rest of Europe | |
    3. 7.3 Asia-Pacific | | |
      1. 7.3.1 China | | |
      2. 7.3.2 India | | |
      3. 7.3.3 Japan | | |
      4. 7.3.4 South Korea | | |
      5. 7.3.5 ASEAN | | |
      6. 7.3.6 Rest of Asia-Pacific | |
    4. 7.4 South America | | |
      1. 7.4.1 Brazil | | |
      2. 7.4.2 Argentina | | |
      3. 7.4.3 Rest of South America | |
    5. 7.5 Middle East & Africa | | |
      1. 7.5.1 Saudi Arabia | | |
      2. 7.5.2 UAE | | |
      3. 7.5.3 South Africa | | |
      4. 7.5.4 Egypt | | |
      5. 7.5.5 Rest of MEA | |
  8. 8 Future Outlook (2026–2035) | |
    1. 8.1 Automation and Machine Learning in Result Interpretation | |
    2. 8.2 Whole-Genome Sequencing at Routine Scale | |
    3. 8.3 Subscription and Platform Economics | |
    4. 8.4 One Health Integration and Supply-Chain Disclosure | |
  9. 9 Segmentation Analysis | |
    1. 9.1 By Offering | | |
      1. 9.1.1 Instruments & Automation Platforms | | |
      2. 9.1.2 Test Kits & Reagents | | |
      3. 9.1.3 Services | |
    2. 9.2 By Test Type | | |
      1. 9.2.1 Conventional Culture Methods | | |
      2. 9.2.2 Immunoassay | | |
      3. 9.2.3 PCR-Based | | |
      4. 9.2.4 Isothermal | | |
      5. 9.2.5 Next-Generation Sequencing | |
    3. 9.3 By Sample Type | | |
      1. 9.3.1 Food | | |
      2. 9.3.2 Feed & Pet Food | | |
      3. 9.3.3 Environmental Samples | | |
      4. 9.3.4 Clinical & Veterinary Samples | | |
      5. 9.3.5 Water & Beverage | |
    4. 9.4 By End-User | | |
      1. 9.4.1 Food & Beverage Manufacturers | | |
      2. 9.4.2 Contract Laboratories | | |
      3. 9.4.3 Government & Regulatory Agencies | | |
      4. 9.4.4 Research & Academic Institutes | | |
      5. 9.4.5 Others | | |
      6. 9.4.6 Healthcare & Clinical Labs | | |
      7. 9.4.7 Veterinary & Animal Health Facilities | |
  10. 10 Competitive Landscape | |
    1. 10.1 Market Concentration Analysis | |
    2. 10.2 Competitive Benchmarking Matrix | |
    3. 10.3 Company Profiles | |
  11. 11 Recent News & Developments | |
  12. 12 Report Scope and Methodology | |
  13. 13 Detailed Sources and Citations | |
  14. 14 Frequently Asked Questions | | LIST OF TABLES | |
  15. TABLE 1 Global Salmonella Testing Market Size & Forecast, by Revenue (USD Billion), 2021–2035 | |
  16. TABLE 2 Global Salmonella Testing Market – Year-over-Year Growth Analysis, 2021–2035 | |
  17. TABLE 3 Driver Impact Analysis – Global Salmonella Testing Market, 2026–2035 | |
  18. TABLE 4 Restraint Impact Analysis – Global Salmonella Testing Market, 2026–2035 | |
  19. TABLE 5 Global Salmonella Testing Market Size, by Region, 2021–2035 (USD Billion) | |
  20. TABLE 6 North America Salmonella Testing Market Size, by Country, 2021–2035 (USD Billion) | |
  21. TABLE 7 Europe Salmonella Testing Market Size, by Country, 2021–2035 (USD Billion) | |
  22. TABLE 8 Asia-Pacific Salmonella Testing Market Size, by Country, 2021–2035 (USD Billion) | |
  23. TABLE 9 South America Salmonella Testing Market Size, by Country, 2021–2035 (USD Billion) | |
  24. TABLE 10 Middle East & Africa Salmonella Testing Market Size, by Country, 2021–2035 (USD Billion) | |
  25. TABLE 11 Global Salmonella Testing Market Size, by Offering, 2021–2035 (USD Billion) | |
  26. TABLE 12 Global Salmonella Testing Market Size, by Test Type, 2021–2035 (USD Billion) | |
  27. TABLE 13 Global Salmonella Testing Market Size, by Sample Type, 2021–2035 (USD Billion) | |
  28. TABLE 14 Global Salmonella Testing Market Size, by End-User, 2021–2035 (USD Billion) | |
  29. TABLE 15 Competitive Benchmarking Matrix – Global Salmonella Testing Market, 2026 | |
  30. TABLE 16 Company Profiles – Key Players, Global Salmonella Testing Market | |
  31. TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 | |
  32. TABLE 18 Report Scope & Methodology Summary | |
  33. TABLE 19 Detailed Sources and Citations Index | |
  34. TABLE 20 Segmentation Quick Reference – Dominant and Fastest Growing Segments | | LIST OF FIGURES | |
  35. FIGURE 1 Global Salmonella Testing Market – Market Dynamics Snapshot | |
  36. FIGURE 2 Industry Value Chain Analysis – Salmonella Testing | |
  37. FIGURE 3 Porter's Five Forces Analysis – Salmonella Testing | |
  38. FIGURE 4 Global Market Size Trend and Forecast, 2021–2035 (USD Billion) | |
  39. FIGURE 5 Year-over-Year Growth Trend, 2022–2035 (%) | |
  40. FIGURE 6 Market Share by Offering, 2025 (%) | |
  41. FIGURE 7 Market Share by Test Type, 2025 (%) | |
  42. FIGURE 8 Market Share by Sample Type, 2025 (%) | |
  43. FIGURE 9 Market Share by End-User, 2025 (%) | |
  44. FIGURE 10 Regional Market Share, 2025 (%) | |
  45. FIGURE 11 Country-Level Share within North America, 2025 (%) | |
  46. FIGURE 12 Country-Level Share within Asia-Pacific, 2025 (%) | |
  47. FIGURE 13 Competitive Landscape – Estimated Revenue Share Bands, 2026 | |
  48. FIGURE 14 Strategic Positioning Map – Key Players

Segmentation Quick Reference

DimensionSub-SegmentsDominant SegmentFastest Growing Segment
By OfferingInstruments & Automation Platforms; Test Kits & Reagents; ServicesTest Kits & Reagents (59.8% share)Services (10.44% CAGR)
By Test TypeConventional Culture Methods; Immunoassay; PCR-Based; Isothermal; Next-Generation SequencingPCR-Based (34.9% share)Isothermal (11.32% CAGR)
By Sample TypeFood; Feed & Pet Food; Environmental Samples; Clinical & Veterinary Samples; Water & BeverageFood (41.6% share)Feed & Pet Food (12.35% CAGR)
By End-UserFood & Beverage Manufacturers; Contract Laboratories; Government & Regulatory Agencies; Research & Academic Institutes; OthersFood & Beverage Manufacturers (31.1% share)Contract Laboratories (10.18% CAGR)
By RegionNorth America; Europe; Asia-Pacific; South America; Middle East & AfricaNorth America (34.1% share)Asia-Pacific (10.12% CAGR)

 

Market Segmentation Overview

By Offering

Sub-SegmentKey Trend
Instruments & Automation PlatformsConsolidation of manual benches into automated liquid-handling decks
Test Kits & ReagentsClosed-system consumables locked to validated instrument ecosystems
ServicesOutsourced sequencing, serotyping, and bioinformatics interpretation

 

Test Kits & Reagents lead this dimension at 59.8% share because every released lot consumes chemistry irrespective of instrument age, and validated consumables cannot be substituted without re-qualification. Services grow fastest at a 10.44% CAGR, driven by processors that will buy sequencing and resistance interpretation but will not staff bioinformatics teams. Instruments & Automation Platforms sit between the two: revenue per placement is rising, yet each automated deck displaces several manual stations, which restrains unit growth.

By Test Type

Sub-SegmentKey Trend
Conventional Culture MethodsRetained as the regulatory confirmation and dispute-resolution reference
ImmunoassayLow-capital screening in cost-constrained and emerging laboratories
PCR-BasedBroadest validated matrix claim library across food categories
IsothermalLAMP panels on battery heaters for on-farm and border use
Next-Generation SequencingSource attribution, persistence mapping and resistance prediction

 

PCR-Based methods hold 34.9% share on the strength of validation depth and a large installed instrument base that buyers are reluctant to strand. Isothermal grows fastest at an 11.32% CAGR because LAMP chemistry runs on simple heaters, cutting the capital threshold for on-farm and inspection-point deployment where PCR is impractical. Conventional Culture Methods remain the confirmatory reference against which alternatives are validated, so their decline is gradual rather than abrupt.

By Sample Type

Sub-SegmentKey Trend
FoodLot-discrete release testing across meat, dairy, produce, and RTE categories
Feed & Pet FoodQuantitative load tracking replacing presence-absence screening
Environmental SamplesZone-based swabbing embedded in HACCP verification
Clinical & Veterinary SamplesZoonotic surveillance and herd health monitoring
Water & BeverageAgricultural and process water controls under produce safety rules

 

Food dominates at 41.6% share because release testing applies to virtually every regulated lot leaving a processing facility. Feed & Pet Food expands fastest at a 12.35% CAGR as antibiotic-free production removes a suppression mechanism, forcing quantitative monitoring from raw ingredient intake through finished pellet. Environmental Samples grow steadily alongside, since auditors now read facility swab data as the earlier and more reliable signal of process control.

By End-User

Sub-SegmentKey Trend
Food & Beverage ManufacturersIn-house PCR and culture workflows tied to release decisions
Contract LaboratoriesAbsorption of sequencing, serotyping, and resistome workloads
Government & Regulatory AgenciesStatutory verification sampling and national surveillance
Research & Academic InstitutesMethod development and outbreak forensics
OthersRetailers, food service groups and certification bodies

 

Food & Beverage Manufacturers lead at 31.1% share because release decisions cannot wait on third-party turnaround, which keeps core screening in-house. Contract Laboratories grow fastest at a 10.18% CAGR, taking on whole-genome SNP comparison and resistome mapping that individual plants cannot staff or justify. Government & Regulatory Agencies provide a stable revenue floor tied to statutory sampling rather than commercial demand cycles, which cushions the industry during downturns.

 

 

 

 

 

 

 

 

 

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.